Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

ETAMZILATE™ injection solution 125mg/ml (2ml), 10pcs

🔥 7 items sold in last 3 hours
24 people are viewing this product
Active Ingredient:

Manufacturer:

$7.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

L-THYROXINE BERLIN CHEMIE™ tablets 100mcg, 100pcs

$10.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 100mcg, 50pcs

$8.00
Add to cart

Analogs of ETAMZILATE™

L-THYROXINE BERLIN CHEMIE™ tablets 100mcg, 100pcs

$10.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 100mcg, 50pcs

$8.00
Add to cart

OLEOS SUPERCHISTOTEL™ solution 5ml, 1pc

$11.00
Add to cart

ABAKTAL™ tablets 400mg, 10pcs

$42.00
Add to cart

Table of Contents

ETAMZILATE™ 125mg/ml Solution Buy Online

ETAMZILATE Injection Solution: A Comprehensive Overview

Uncontrollable bleeding can be a life-threatening emergency. Etamzilate injection solution offers a rapid and effective means of managing various types of hemorrhages. Understanding its properties and applications is crucial for healthcare professionals.

This overview details the uses, mechanisms, and potential side effects of etamzilate, a hemostatic agent commonly administered via injection. It’s vital to consult a medical professional for diagnosis and treatment.

Etamzilate’s versatility extends across numerous medical specialties, proving invaluable in managing various bleeding episodes. This makes it a crucial tool in many clinical settings.

What is Etamzilate?

Etamzilate is a synthetic hemostatic drug. It’s a medication primarily used to control and prevent bleeding, particularly capillary bleeding. Its mechanism of action involves multiple pathways, contributing to its effectiveness in various clinical situations.

Unlike some other hemostatic agents that focus solely on clotting factors, etamzilate works by influencing several aspects of the bleeding process. This multifaceted approach makes it a versatile option for managing hemorrhages.

Specifically, etamzilate enhances platelet aggregation and strengthens capillary walls. This dual action reduces capillary fragility and promotes the formation of stable blood clots. The result is a more effective stoppage of bleeding.

Available in various formulations, including injection solutions, etamzilate’s administration method often depends on the severity and location of the bleeding. Intravenous and intramuscular routes are common for rapid effect, while other methods may be used.

The drug’s impact on platelet function and capillary integrity contributes significantly to its hemostatic properties. Its widespread use in diverse medical settings highlights its clinical significance. Always follow the prescribed dosage and administration guidelines carefully.

It’s crucial to remember that etamzilate is a prescription medication and should only be used under the guidance of a qualified healthcare professional. Self-medication is strongly discouraged.

Further research into etamzilate continues to expand our understanding of its mechanism of action and broaden its therapeutic applications. This ongoing investigation promises even greater clinical utility in the future.

Therapeutic Uses of Etamzilate

Etamzilate’s primary therapeutic application lies in its ability to control and prevent bleeding. Its multifaceted mechanism of action makes it effective across a range of bleeding scenarios, from minor to severe.

Surgical procedures frequently benefit from etamzilate’s prophylactic use. Administered before or during surgery, it can significantly reduce the risk of postoperative bleeding, particularly in highly vascularized tissues.

In obstetrics and gynecology, etamzilate finds use in managing menorrhagia (heavy menstrual bleeding) and postpartum hemorrhage. Its ability to strengthen capillary walls and promote platelet aggregation contributes to its effectiveness in these cases.

Beyond surgical settings, etamzilate proves valuable in treating various types of bleeding episodes. These include, but aren’t limited to, epistaxis (nosebleeds), gingival bleeding (bleeding gums), and hematuria (blood in the urine).

Furthermore, etamzilate plays a role in managing bleeding complications associated with certain medical conditions. For example, it can be used to address bleeding related to diabetic microangiopathy or other conditions affecting capillary integrity.

The versatility of etamzilate extends to ophthalmology, where it’s sometimes used to manage bleeding in the eye. However, its applications in ophthalmology should be guided by a specialist.

It’s important to note that while etamzilate is effective in managing various bleeding episodes, it’s not a replacement for other necessary treatments. It should be used as part of a comprehensive treatment plan determined by a healthcare professional.

The use of etamzilate should always be guided by a physician’s assessment of the patient’s condition and other factors that may influence treatment decisions. Individual responses to medication can vary.

Conditions Treated with Etamzilate

Etamzilate’s therapeutic applications span a wide range of conditions characterized by capillary bleeding or increased bleeding risk. Its ability to enhance platelet function and strengthen capillary walls makes it a valuable tool in various medical specialties.

One significant application is in the management of post-surgical bleeding. Etamzilate’s prophylactic use before or after procedures can minimize hemorrhagic complications, particularly in surgeries involving highly vascular tissues.

Conditions affecting the integrity of blood vessels, such as diabetic microangiopathy, often benefit from etamzilate treatment. By strengthening capillaries, it can help reduce bleeding episodes associated with this complication of diabetes.

Furthermore, etamzilate finds use in treating various types of spontaneous bleeding. This includes epistaxis (nosebleeds), menorrhagia (heavy menstrual bleeding), and gingival bleeding (bleeding gums). Its action on both platelets and capillaries contributes to its efficacy.

In ophthalmology, etamzilate may be used to manage bleeding within the eye, though this application requires specialized medical expertise. Careful consideration of potential risks and benefits is necessary in such cases.

Other conditions where etamzilate may be considered include certain types of hematuria (blood in the urine) and other instances of capillary fragility. However, the appropriateness of etamzilate use depends on the underlying cause and overall clinical picture.

While etamzilate is effective in managing bleeding in these conditions, it’s crucial to remember that it is not a standalone treatment. It should be used in conjunction with other necessary medical interventions, as determined by a physician.

Always consult with a healthcare professional to determine if etamzilate is the appropriate treatment for your specific condition. They will assess your individual needs and potential risks before prescribing the medication.

Administration and Dosage of Etamzilate

The administration and dosage of etamzilate vary depending on the specific clinical indication and the patient’s individual needs. Always adhere to the prescribing physician’s instructions; this information is for general knowledge only and should not be considered medical advice.

For intravenous administration, etamzilate is typically injected slowly. Rapid injection should be avoided to minimize the risk of adverse effects. The rate of injection and the total dose are determined by the treating physician.

Intramuscular injection is another common route of administration. The injection site should be chosen carefully to minimize discomfort and potential complications. The dosage and frequency of intramuscular injections are dictated by the specific clinical situation.

In some cases, etamzilate may be administered subconjunctivally or retrobulbarly, primarily in ophthalmological settings. These specialized administration methods require the expertise of an ophthalmologist and are not typically performed outside of a medical facility.

Dosage is usually determined by the severity of the bleeding and the patient’s overall health. The physician will consider various factors, including the patient’s age, weight, and other medical conditions, when determining the appropriate dosage.

Typical adult dosages range from 125mg to 250mg, given at intervals determined by the physician’s assessment. Children’s dosages are significantly lower and always calculated based on weight and medical condition.

It’s crucial to emphasize that incorrect administration or dosage can lead to adverse effects. Always follow the instructions provided by your healthcare professional precisely. Never attempt to self-administer etamzilate.

Close monitoring by a medical professional is vital, especially during initial treatment. The response to etamzilate can vary among individuals, and adjustments to the treatment plan may be necessary based on clinical response.

Mechanism of Action

Etamzilate’s hemostatic effect is multifaceted, involving several key mechanisms that contribute to its effectiveness in controlling and preventing bleeding. Understanding these mechanisms is crucial for appreciating its clinical utility.

One primary mechanism is the enhancement of platelet aggregation. Etamzilate promotes the adhesion and aggregation of platelets, crucial components in blood clot formation. This action helps to stabilize the initial plug at the site of bleeding.

Beyond platelet function, etamzilate also affects capillary integrity. It strengthens capillary walls, reducing their permeability and thus minimizing leakage of blood from smaller vessels. This action is vital in controlling capillary bleeding.

Furthermore, etamzilate influences the formation of tissue thromboplastin. This factor is essential in the coagulation cascade, the complex series of biochemical reactions leading to clot formation. Etamzilate’s effect on this process accelerates clot formation.

The precise molecular mechanisms underlying etamzilate’s actions remain a subject of ongoing research. However, the observed effects on platelet aggregation, capillary permeability, and tissue thromboplastin formation clearly contribute to its hemostatic properties.

This multi-pronged approach distinguishes etamzilate from other hemostatic agents that may target only specific aspects of the coagulation process. Its ability to impact multiple stages of hemostasis contributes to its broad clinical applicability.

While the exact details of its molecular interactions are still being elucidated, the observed effects on platelet function, capillary walls, and the coagulation cascade clearly demonstrate its efficacy in controlling and preventing bleeding.

The combined effects on platelet aggregation, capillary resistance, and the coagulation cascade explain etamzilate’s efficacy in diverse bleeding scenarios. This makes it a valuable tool in the management of various hemorrhagic conditions.

Potential Side Effects

While generally well-tolerated, etamzilate, like all medications, can cause adverse effects in some individuals. These side effects are typically mild and transient, but it’s crucial to be aware of the possibilities.

Gastrointestinal disturbances, such as nausea, dyspepsia (indigestion), and epigastric discomfort, are among the most commonly reported side effects. These are usually mild and resolve without specific intervention.

Less frequent but still possible side effects include headaches and dizziness. These neurological symptoms are generally mild and self-limiting, but patients experiencing persistent or severe symptoms should seek medical attention.

Allergic reactions, although uncommon, can occur. These reactions can manifest in various ways, from mild skin rashes to more severe systemic reactions. Patients with a known allergy to etamzilate or its components should avoid the medication.

Changes in blood pressure, either increases or decreases, have been reported in some cases. These fluctuations are usually minor and transient, but patients with pre-existing hypertension or hypotension should be monitored closely.

Rare instances of paresthesia (numbness or tingling) in the extremities have been observed. This is usually a temporary effect, but persistent paresthesia warrants medical evaluation.

It is important to note that the frequency and severity of side effects can vary significantly among individuals. Patients experiencing any concerning symptoms should promptly consult their healthcare provider.

This information is not exhaustive, and other less common side effects may occur. Always report any unexpected or concerning symptoms to your doctor or pharmacist. They can assess the situation and provide appropriate guidance.

Pros of Using Etamzilate

Etamzilate offers several advantages in the management of bleeding, making it a valuable tool in various clinical settings. Its multifaceted mechanism of action contributes to its effectiveness and versatility.

One key advantage is its rapid onset of action. When administered intravenously, etamzilate can quickly help control bleeding, which is crucial in emergency situations. This rapid effect is a significant benefit in managing acute hemorrhages.

Etamzilate’s versatility is another significant advantage. It can be used to treat a wide range of bleeding conditions, from minor injuries to more serious surgical complications. This broad applicability makes it a useful medication for many healthcare professionals.

Furthermore, etamzilate is often well-tolerated by patients, with side effects generally being mild and transient. This favorable safety profile is an important consideration, particularly in patients with pre-existing medical conditions.

Its use as a prophylactic agent before or after surgery helps minimize the risk of postoperative bleeding, reducing the need for additional interventions and potentially improving patient outcomes. This preventative capacity is a significant advantage.

The ability to administer etamzilate via multiple routes (intravenous, intramuscular, subconjunctival, retrobulbar) provides flexibility in treatment approaches. This adaptability allows healthcare providers to tailor administration based on the specific clinical needs.

Finally, etamzilate’s relatively low cost compared to some other hemostatic agents makes it an accessible and cost-effective treatment option in many healthcare systems. This affordability enhances its availability to patients who need it.

While possessing these advantages, it’s vital to remember that etamzilate’s use should always be guided by a healthcare professional’s assessment of the individual patient’s condition and needs. This ensures safe and effective use.

Cons of Using Etamzilate

While etamzilate offers numerous benefits, potential drawbacks should be considered. Understanding these limitations helps ensure responsible and informed use of the medication.

One potential drawback is the occurrence of side effects, although generally mild. These can include gastrointestinal upset, headaches, dizziness, and allergic reactions. The risk of side effects varies among individuals.

Although rare, serious allergic reactions are possible. Patients with known allergies should exercise caution and discuss potential risks with their healthcare provider before using etamzilate. Careful monitoring is necessary in such cases.

Etamzilate’s effect on blood pressure, while usually minor, can be a concern for individuals with pre-existing hypertension or hypotension. Close monitoring of blood pressure during treatment is advisable, particularly in vulnerable patients.

The mechanism of action, while effective, is not fully understood at the molecular level. This lack of complete mechanistic understanding limits our predictive capacity regarding individual responses and potential interactions with other medications.

Furthermore, etamzilate’s effectiveness can vary depending on the specific bleeding condition and the individual patient’s response. It may not be as effective as other treatments in all cases, requiring careful consideration of alternative therapies.

Finally, while generally safe, using etamzilate necessitates close medical supervision, especially during initial treatment. Regular monitoring allows for prompt detection and management of any adverse effects or lack of efficacy.

Despite these potential downsides, the benefits of etamzilate often outweigh the risks for many patients. However, a thorough risk-benefit assessment by a healthcare professional is always crucial before initiating treatment.

Contraindications and Precautions

While generally safe, etamzilate is not suitable for all patients. Certain conditions necessitate caution or contraindicate its use. Understanding these contraindications and precautions is crucial for safe and effective treatment.

A known allergy to etamzilate or any of its components is a clear contraindication. Patients with a history of allergic reactions to this medication should avoid using it. Alternative hemostatic agents should be considered.

Severe hepatic or renal impairment may necessitate caution or contraindicate etamzilate use. The medication’s metabolism and excretion may be affected in patients with these conditions, potentially increasing the risk of adverse effects. Careful monitoring is required.

Patients with a history of thromboembolic events, such as deep vein thrombosis or pulmonary embolism, should use etamzilate with extreme caution. Its pro-coagulant effects could potentially increase the risk of further thrombotic events. The physician must carefully weigh the risks and benefits.

Pregnant and breastfeeding women should discuss the use of etamzilate with their healthcare provider. While studies haven’t shown significant adverse effects in pregnancy or lactation, the physician should assess the potential risks and benefits individually.

Patients with pre-existing conditions affecting blood pressure, such as hypertension or hypotension, require close monitoring during etamzilate treatment. The medication can affect blood pressure, necessitating careful observation and adjustment of dosage if necessary.

It’s crucial to inform your doctor about all medications you are currently taking, including over-the-counter drugs and herbal supplements. Potential interactions with other medications should be carefully considered before starting etamzilate therapy.

Always provide a complete medical history to your doctor, including details of any allergies, pre-existing conditions, and current medications. This information enables the physician to make informed decisions regarding the appropriateness and safety of etamzilate treatment.

  • Etamzilate™ Injection Solution 125Mg/Ml (2Ml), 10Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Etamzilate™ Injection Solution 125Mg/Ml (2Ml), 10Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Etamzilate™ Injection Solution 125Mg/Ml (2Ml), 10Pcs Buy Online 6
    [Medical reviewer]

    Dr. Lewis Rappaport is a highly experienced and respected cardiologist who serves as a salaried specialist and consultant for the licensed online pharmacy, RxPulsar.com. With over 30 years of practice...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “ETAMZILATE™ injection solution 125mg/ml (2ml), 10pcs”

Your email address will not be published. Required fields are marked

Similar products

TRANEXAM™ tablets 250mg, 10pcs

$20.00
Add to cart

TRANEXAM™ tablets 250mg, 30pcs

$42.00
Add to cart

TRANEXAM™ tablets 500mg, 10pcs

$29.00
Add to cart

TACHOCOMB™ sponge 4.8×4.8×0.5cm, containers 2pcs

$1,555.00
Add to cart

PROTAMINE SULFATE solution for IV injection 10mg/ml (5ml), ampoules 5pcs

$70.00
Add to cart

Water pepper liquid extract for oral use 25ml, 1pc

$8.00
Add to cart

Water pepper liquid extract for oral use 25ml, 1pc

$7.00
Add to cart

SHEPHERD’S PURSE herb tea bags 1.5g, 20pcs

$8.00
Add to cart

NETTLE LEAF filter bags 1.5g, 20pcs

$7.00
Add to cart

STINGING NETTLE leaves 35g, pack 1pc

$9.00
Add to cart

STINGING NETTLE leaves 1.5g, filter bags 20pcs

$7.00
Add to cart

DICYNONE™ tablets 250mg, 100pcs

$50.00
Add to cart

VIKASOL™ tablets 15mg, 20pcs

$7.00
Add to cart

VIKASOL™ solution for intramuscular injection 10mg/ml (1ml), ampoules 10pcs

$8.00
Add to cart

VIKASOL™ solution for intramuscular injection 10mg/ml (1ml), 10pcs

$7.00
Add to cart

AMINOCAPROIC ACID 5% infusion solution (100ml), 1pc

$18.00
Add to cart
Select your currency